APA (7th ed.) Citation

Lorenzo A. Calò, Lucia Federica Stefanelli, & Federico Nalesso. (2022). Angiotensin II, RAS activation and RAS blockers in COVID-19: Unambiguous evidence. Karger Publishers.

Chicago Style (17th ed.) Citation

Lorenzo A. Calò, Lucia Federica Stefanelli, and Federico Nalesso. Angiotensin II, RAS Activation and RAS Blockers in COVID-19: Unambiguous Evidence. Karger Publishers, 2022.

MLA (9th ed.) Citation

Lorenzo A. Calò, et al. Angiotensin II, RAS Activation and RAS Blockers in COVID-19: Unambiguous Evidence. Karger Publishers, 2022.